Only 11 percent of docs say that info provided by sales reps greatly affects their prescribing decisions, and only 24 percent report that the info is very useful in staying informed about drugs, according to a new survey of 501 office and hospital-based docs by PhRMA, the industry trade group.
Moreover, only 8 percent do any prescribing based on info received solely from sales reps, and just 29 percent say they are very satisfied with info reps deliver. At the same time, 30 percent docs want to get drug info from reps, and more than half like the info on drug interactions and the free samples.
So where do docs like to get their info? 69 percent say CME is very useful and 67 percent like peer-reviewed journals. And 92 percent trust their own clinical experience when prescribing. Docs also weigh a patient's situation, clinical guidelines, journals and formulary coverage ahead of reps.
In touting the results, PhRMA ceo Billy Tauzin says the "survey shows that doctors rely on a wide variety of information to make important prescribing decisions..." Here is the full statement with a link to charts.
Of course, there are other ways to intepret the findings. PhRMA may now argue the drumbeat of complaints that reps have outsized influence on prescribing is inaccurate. And drugmakers may use the data to further eliminate still more reps. In some circles, this is called a win-win - unless, you're a rep.